PeptideStack
5.2kquestions
20kanswers
220users

Can I reconstitute a GLP-1 receptor agonist at 6.67 mg/mL and still measure a small dose accurately?

Asked 2 Feb 2025Modified 14 months agoViewed 17k times
23

What I have: a GLP-1 receptor agonist · 6.67 mg/mL.

I would rather over-plan the first cycle and simplify later.

I am prepared to do the work if someone can tell me which work matters.

How do I make this decision on evidence rather than on feel?

diluent-volume
diluent-volume

Choosing how much diluent to add, which is really a question about what you want your measurement resolution to be. Larger volumes buy you…

295 questions
insulin-syringe
insulin-syringe

U-100 and U-40 insulin syringes as measuring instruments. A U-100 syringe is graduated in insulin units where 100 units equals 1 mL, so one unit…

244 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questions
shareeditfollowflag
CM
askedcarys_meredith12k162 Feb 2025
2Same question, and I got two answers that differ by a factor of ten, so I am watching this. – RP_C18 8 months ago
add a comment

5 Answers

Sorted by votes
4

At 6.67 mg/mL a 0.25 mg dose is 3.7 units on a U-100 barrel and a 1 mg dose is 15 units. Volume is dose divided by concentration and one unit is 0.01 mL, so the unit count is dose ÷ 6.67 × 100. That puts the smaller dose below five units, where a half-graduation misread is more than ten per cent of the dose — reconstitute to a lower concentration if small doses are the point.

Answer first: diluent volume sets concentration and therefore resolution on the syringe barrel, and resolution is free at reconstitution and impossible to recover afterwards.

Worked example. A 10 mg vial reconstituted with 2 mL gives 5 mg/mL. A 0.5 mg dose is 0.5 ÷ 5 = 0.1 mL, which on a U-100 syringe is 10 units. Reconstitute the same vial with 1 mL and the concentration doubles to 10 mg/mL, the same dose becomes 0.05 mL, and you are now reading 5 units instead of 10 — the same dose at half the resolution.

To be exact about it, vial headspace is the hard constraint. A nominal 2 mL vial typically holds a little over 2 mL to the shoulder; adding 3 mL is not an option and attempting it wastes the lot.

The caveat is that this arithmetic assumes the vial contains what the label says, and without a content assay it is precise about an unknown quantity.

Choose the volume that puts your largest intended dose between 10 and 30 units. Everything else follows.

edited 25 Feb 2025 by Dr_Idris_Coulibaly — fixed an arithmetic slip in the third paragraph

shareimprove this answerflag
DC
answeredDr_Idris_Coulibaly33k1374 Feb 2025
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
4

The short version: more diluent means a lower concentration, a larger volume per dose and a finer reading; less means the opposite.

Content matters. If the same 10 mg vial assays at 94 per cent content, you have 9.4 mg. In 2 mL that is 4.7 mg/mL, and a nominal 0.5 mg draw of 10 units actually delivers 0.47 mg — a six per cent shortfall that no amount of careful drawing will fix.

Round to a diluent volume you can measure accurately. Measuring 1.00 mL on a 1 mL syringe is reliable; measuring 1.37 mL on anything is not, and the error propagates into every dose.

A concentration calculated to three decimal places from a diluent volume measured to one is false precision.

Measure a volume you can actually measure. Round numbers, real syringes.

shareimprove this answerflag
GW
answeredgel_pack_warm13k2715 Feb 2025
4

The relevant arithmetic is concentration equals vial content divided by diluent volume, and content is not the same as label claim.

Dead-space loss scales with the number of draws, not with the concentration, so a lower concentration spread over more draws loses proportionally less of the total peptide.

Write the concentration and the resulting units-per-dose on the vial label at reconstitution. The arithmetic that is obvious now will not be obvious at six in the morning three weeks from now.

Published content assay results across the independent testing services show nominal and measured content differing by one to ten per cent, which makes content the dominant term in dose error.

Do not change the diluent volume between vials of a titration without recalculating; it is the commonest source of a ten-fold error.

Write the concentration on the label at reconstitution, in units per dose.

shareimprove this answerflag
OK
answeredoona_kekkonen13k1713 May 2025
5Thank you — the worked example is what makes this usable. – e_dziedzic 4 days ago
6Would this be different for a peptide that foams? Mine does and I have never known why. – cap_the_luer 2 months ago
add a comment
4

Aim for a dose volume somewhere between about 10 and 30 units on a U-100 barrel and the reading problem disappears.

For a dose that will change during titration, choose the volume for the largest intended dose rather than the first, so the whole schedule fits on one barrel without a mid-vial recalculation.

Check the vial can physically hold the volume before you draw it up.

shareimprove this answerflag
TN
answeredtabular_nums71k4824 May 2025
6Adding a vote because this deserves more of them. – nine_point_nine 3 months ago
add a comment
-2

Start from the dose you intend to draw and work backwards to the volume that puts it in a readable part of the barrel.

The other direction: 10 mg in 3 mL is 3.33 mg/mL, and a 0.5 mg dose becomes 0.15 mL, or 15 units. More barrel, easier reading, and a larger fraction of the vial volume lost to dead space across the same number of draws.

Insulin syringe barrel graduations are typically 1 unit on a 0.3 mL barrel, 1 unit on a 0.5 mL barrel and 2 units on a 1 mL barrel, which is why the barrel size changes what is readable.

Nothing here is medical advice, and research-use material is not approved for human use.

Concentration equals content over volume, and content is not label claim.

shareimprove this answerflag
LC
answeredlyoph_cake78k26710 Mar 2025
3Thank you — this is the answer I was looking for. – noor_alhassan 2 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.